Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$46.37
+14.79%
Mkt Cap $2.25B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$43.33
Range $39.00 – $52.00
Implied Upside
-6.5%
Consensus $43.33 vs current $46.37
NASDAQ·Healthcare·Biotechnology
$46.37
+14.79%
Mkt Cap $2.25B
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$43.33
Range $39.00 – $52.00
-6.5%
Consensus $43.33 vs current $46.37